Why Wegovy Slows Digestion, and What to Expect

What the clinical evidence says about gastric emptying and semaglutide

The STEP 1 trial (published in the New England Journal of Medicine and involving nearly 2,000 adults with obesity) gave researchers an unusually clear picture of how semaglutide produces weight loss. Participants lost an average of around 15% of body weight over 68 weeks at the 2.4mg maintenance dose. Much of that effect traced back to a single physiological change: food moving more slowly out of the stomach.

GLP-1 receptors sit in the gut wall and in appetite-regulating areas of the brain. When semaglutide binds to them, it does two things at once. It signals the brain to reduce hunger, and it relaxes the valve between the stomach and small intestine (the pylorus) so that the stomach empties at roughly half its usual rate in the hours after a meal. The result is a sustained sense of fullness that most people on treatment describe as simply not feeling hungry in the same way they used to.

This is not an unwanted side effect that the manufacturer is still trying to eliminate. It is the intended pharmacology. Knowing that reframes how to interpret early discomfort: the symptoms many people notice in the first weeks are the mechanism working, not evidence that something has gone wrong. That said, how pronounced the effect feels varies considerably from person to person, and a prescriber can help distinguish normal adjustment from a response that needs clinical attention.

Which digestive symptoms are linked to slowed gastric emptying, and when they tend to ease

Because food lingers longer in the stomach, a familiar cluster of symptoms can appear, especially when treatment starts or the dose increases. Nausea is the most commonly reported; it tends to peak in the first day or two after an injection and fade before the next one. Indigestion and a sense of pressure or bloating after eating are also typical, if you want more detail on that specific experience, the guide to Wegovy and indigestion covers practical strategies. Constipation occurs because the slower transit through the gut means the bowel moves less often. Some people notice the opposite, particularly early on.

A common misconception is that persistent nausea means the medicine is too strong or the wrong choice. For most people it settles within two to four weeks as the body adjusts to each dose level, and it becomes less noticeable again once the dose is stable. The titration schedule exists precisely to give the gut time to adapt before the dose rises further.

Symptoms worth reporting promptly are different in character: severe stomach pain that reaches through to the back, vomiting that prevents keeping fluids down, or signs of dehydration. The MHRA's Yellow Card scheme allows patients to report suspected side effects directly to the regulator, and it is worth knowing that route exists. Any symptom that feels sharp, persistent or worsening rather than gradually improving deserves a call to your prescriber rather than a wait-and-see approach.

Practical ways to eat around slowed digestion without undermining treatment

Working with a slower stomach rather than against it is mostly about portion size and pace. Smaller meals, eaten slowly, cause far less discomfort than the same food consumed quickly or in a single large plate. Fatty and heavily processed foods delay gastric emptying further still, layering that on top of semaglutide's effect can amplify nausea considerably. Plain, protein-rich foods tend to be better tolerated in the early weeks.

Timing also matters. Eating within an hour or two of your injection day is when many people feel worst; some find it easier to inject in the evening so the peak effect passes overnight. There is no fixed rule (individual patterns vary) and your prescriber is best placed to advise around your specific routine.

Hydration is worth taking seriously. Slower digestion combined with reduced food intake can mean fluid intake drops too, which compounds any constipation. Sipping water consistently through the day rather than in large amounts at mealtimes tends to help. If digestive changes feel connected to a broader slowdown in your weight loss, the page on slow weight loss with Wegovy looks at what's normal over the course of treatment and what might warrant a conversation with a clinician. Cost and treatment planning questions are addressed on the Wegovy price comparison page, if that is useful context alongside starting treatment.

What this means if you are considering Wegovy

The slowing of digestion is inseparable from Wegovy's effectiveness. You cannot have one without the other. For most people the adjustment is manageable, and by the time the maintenance dose is reached the worst of the early symptoms has usually passed. The full Wegovy overview sets out eligibility, the titration schedule and how treatment is reviewed, and our semaglutide page explains how the medicine works across its licensed uses.

Prescribers at nume review every consultation personally, a real clinician reads your health history, not an automated queue. If you have questions about whether Wegovy is likely to suit you, or how digestive side effects should be managed in your particular circumstances, the Wegovy questions page and our FAQs cover a wide range of what patients ask most. Our clinical team is there to make that assessment properly. When you are ready, you can start your free consultation and have your answers reviewed the same day.